Kitano S - Search Results

1

Nakayama T, Kitano S. Nakayama T, et al. Among authors: kitano s. Int J Urol. 2019 Mar;26(3):326-333. doi: 10.1111/iju.13902. Epub 2019 Feb 1. Int J Urol. 2019. PMID: 30710374 Review.

2

Clinical Development of Immune Checkpoint Inhibitors.

Ito A, Kondo S, Tada K, Kitano S. Ito A, et al. Among authors: kitano s. Biomed Res Int. 2015;2015:605478. doi: 10.1155/2015/605478. Epub 2015 Jun 16. Biomed Res Int. 2015. PMID: 26161407 Free PMC article. Review.

3

Tremelimumab-associated tumor regression following after initial progression: two case reports.

Shimomura A, Fujiwara Y, Kondo S, Kodaira M, Iwasa S, Kitano S, Tanabe Y, Tamura K, Yamamoto N. Shimomura A, et al. Among authors: kitano s. Immunotherapy. 2016;8(1):9-15. doi: 10.2217/imt.15.89. Epub 2015 Oct 2. Immunotherapy. 2016. PMID: 26427600 Free article.

4

[III. Recent Clinical Development of Cancer Immunotherapy and Speculation for Bone and Soft Tissue Tumors].

Kitano S. Kitano S. Gan To Kagaku Ryoho. 2017 Mar;44(3):222-226. Gan To Kagaku Ryoho. 2017. PMID: 28400545 Japanese. No abstract available.

5

[Development of immune checkpoint inhibitors].

Kitano S. Kitano S. Rinsho Ketsueki. 2017;58(8):966-976. doi: 10.11406/rinketsu.58.966. Rinsho Ketsueki. 2017. PMID: 28883282 Japanese.

6

[Combination Therapy of Immune Checkpoint Inhibitors].

Kitano S. Kitano S. Gan To Kagaku Ryoho. 2017 Sep;44(9):727-732. Gan To Kagaku Ryoho. 2017. PMID: 28912397 Japanese.

7

Biomarkers for Immune Checkpoint Inhibitors in Melanoma.

Kitano S, Nakayama T, Yamashita M. Kitano S, et al. Front Oncol. 2018 Jul 18;8:270. doi: 10.3389/fonc.2018.00270. eCollection 2018. Front Oncol. 2018. PMID: 30073150 Free PMC article. Review.

8

First-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody, in patients with advanced solid tumors.

Shitara K, Ueha S, Shichino S, Aoki H, Ogiwara H, Nakatsura T, Suzuki T, Shimomura M, Yoshikawa T, Shoda K, Kitano S, Yamashita M, Nakayama T, Sato A, Kuroda S, Wakabayashi M, Nomura S, Yokochi S, Ito S, Matsushima K, Doi T. Shitara K, et al. Among authors: kitano s. J Immunother Cancer. 2019 Jul 24;7(1):195. doi: 10.1186/s40425-019-0677-y. J Immunother Cancer. 2019. PMID: 31340866 Free PMC article. Clinical Trial.

9

Severe colitis after PD-1 blockade with nivolumab in advanced melanoma patients: potential role of Th1-dominant immune response in immune-related adverse events: two case reports.

Yoshino K, Nakayama T, Ito A, Sato E, Kitano S. Yoshino K, et al. Among authors: kitano s. BMC Cancer. 2019 Oct 29;19(1):1019. doi: 10.1186/s12885-019-6138-7. BMC Cancer. 2019. PMID: 31664934 Free PMC article.

10

First-in-human study of the cancer peptide vaccine TAS0313 in patients with advanced solid tumors.

Kondo S, Shimizu T, Koyama T, Sato J, Iwasa S, Yonemori K, Fujiwara Y, Shimomura A, Kitano S, Tamura K, Yamamoto N. Kondo S, et al. Among authors: kitano s. Cancer Sci. 2021 Apr;112(4):1514-1523. doi: 10.1111/cas.14765. Epub 2021 Feb 25. Cancer Sci. 2021. PMID: 33615628 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,189 results

Search Page